Pharmaceutical
Learn about the latest developments in the pharmaceutical cannabis industry with Business of Cannabis. Discover new drugs, research, and more.
Pharmaceutical · page 16
- Pharmaceutical
Oxford Cannabinoid Technologies secures drug development agreements
The agreements follow its post-IPO review after its £16.5m fundraise and admission to the main market on LSE in May this year.
- Pharmaceutical
New Listing Proposals Could Exclude Cannabis Startups From The London Stock Exchange
PROPOSALS to set a minimum valuation level for companies looking to list on the London Stock Exchange could limit the number of cannabis entrants to the market.
- Pharmaceutical
UK firm signs deal to speed up development of cannabis-based drugs
Oxford Cannabinoid Technologies has signed a deal with drug development firm Evotec as it moves towards Phase 1 clinical trials in humans.
- Pharmaceutical
UK Home Office grants high-THC medical cannabis licence for £300,000 research facility
Construction on the purpose-built facility in Lincolnshire is expected to commence in July.
- Cultivation
UK Cannabis Cultivation Staff In Short-Supply Due To Post-Brexit Seasonal Labour Shake-UP
CHANGES to immigration policy post-Brexit has resulted in a shortage of seasonal labour at UK-based medicinal cannabis cultivation sites, claims the company that owns Britain’s largest such operation.
- Pharmaceutical
Industry Concerns Surface Over No 10 Taskforce’s Hemp And Cannabis Proposals
THE initial warm welcome to proposals to make UK cannabinoid regulations a matter for the health authorities – not the criminal ones – have cooled in recent days.
- Pharmaceutical
New Era Beckons For Swiss Medical Cannabis Patients After Ten Years In Slow Lane
THE impending change to Switzerland’s medical cannabis laws could see the number of patients receiving treatment rise from 3,000 a year to over 100,000 by 2023.
- Pharmaceutical
How Britain’s Three Crown Dependencies Are Stealing A Cannabis March On the Mainland
FRUSTRATED by the UK Government’s stance the three UK Crown Dependencies of Jersey, Guernsey and the Isle of Man, have taken matters into their own hands.
- Pharmaceutical
‘Patient Capital’ Backing LSE Debutant As It Eyes A Multi-Billion Pound Prize
LONDON Stock Exchange debutant Oxford Cannabinoid Technologies is aiming to emulate the success of GW Pharmaceuticals.
- Pharmaceutical
Weekend digest: Six big stories from the cannabis world you might have missed
Been busy? Get caught up on all the must read news you might have missed this week
- Pharmaceutical
Oxford Cannabinoid Technologies to list on London Stock Exchange
The medical cannabis company will list on the prestigious market on May 21
- Pharmaceutical
British Biotech Firm To List on the London Stock Exchange With A Valuation of Over £50m
BIOTECH company Oxford Cannabinoid Technologies to float on the London Stock Exchange in a listing which is set to value it at £51.5m It says it will raise £16.5m from a ‘heavily oversubscribed’ initial public offering and enter the market this Friday.
